Literature DB >> 24640980

Differential diagnosis of Huntington's disease: what the clinician should know.

Francisco Cardoso1.   

Abstract

Huntington's disease (HD), an autosomal-dominant illness caused by an expansion of the CAG repeats on the short arm of chromosome 4, is clinically characterized by a combination of movement disorders, cognitive decline and behavioral changes. HD accounts for 90-99% of patients who present with this clinical picture. The remaining patients that are negative for the HD genetic mutation are said to have HD phenocopies. Autosomal-dominant diseases that can mimic HD are HD-like 2, C9orf72 mutations, spinocerebellar ataxia type 2, spinocerebellar ataxia type 17 (HD-like 4), benign hereditary chorea, neuroferritinopathy (neurodegeneration with brain iron accumulation type 3), dentatorubropallidoluysian atrophy and HD-like 1. There are also autosomal-recessive choreas that can be HD phenocopies: Friedreich's ataxia, neuroacanthocytosis, several forms of neurodegeneration with brain iron accumulation, ataxia telangiectasia, HD-like 3 and ataxia with oculomotor apraxia. Among X‑linked conditions, McLeod syndrome can mimic the clinical features of HD. Although less frequently, sporadic conditions, such as tardive dyskinesia and non-Wilsonian hepatolenticular degeneration, can also mimic HD.

Entities:  

Mesh:

Year:  2014        PMID: 24640980     DOI: 10.2217/nmt.13.78

Source DB:  PubMed          Journal:  Neurodegener Dis Manag        ISSN: 1758-2024


  7 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-24       Impact factor: 3.575

Review 2.  Iron and Neurodegeneration: Is Ferritinophagy the Link?

Authors:  Giorgio Biasiotto; Diego Di Lorenzo; Silvana Archetti; Isabella Zanella
Journal:  Mol Neurobiol       Date:  2015-10-14       Impact factor: 5.590

3.  Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in Vivo.

Authors:  Robert O'Brien; Francesco DeGiacomo; Jennifer Holcomb; Akilah Bonner; Karen L Ring; Ningzhe Zhang; Khan Zafar; Andreas Weiss; Brenda Lager; Birgit Schilling; Bradford W Gibson; Sylvia Chen; Seung Kwak; Lisa M Ellerby
Journal:  J Biol Chem       Date:  2015-05-29       Impact factor: 5.157

Review 4.  Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.

Authors:  Nicki Niemann; Joseph Jankovic
Journal:  Drugs       Date:  2018-04       Impact factor: 9.546

5.  Combining Literature Review With a Ground Truth Approach for Diagnosing Huntington's Disease Phenocopy.

Authors:  Quang Tuan Rémy Nguyen; Juan Dario Ortigoza Escobar; Jean-Marc Burgunder; Caterina Mariotti; Carsten Saft; Lena Elisabeth Hjermind; Katia Youssov; G Bernhard Landwehrmeyer; Anne-Catherine Bachoud-Lévi
Journal:  Front Neurol       Date:  2022-02-10       Impact factor: 4.086

6.  Benign hereditary chorea, not only chorea: a family case presentation.

Authors:  Jeanette Koht; Sven Olav Løstegaard; Iselin Wedding; Marie Vidailhet; Malek Louha; Chantal Me Tallaksen
Journal:  Cerebellum Ataxias       Date:  2016-02-02

7.  Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels.

Authors:  Barbara J Bailus; Stephen M Scheeler; Jesse Simons; Maria A Sanchez; Kizito-Tshitoko Tshilenge; Jordi Creus-Muncunill; Swati Naphade; Alejandro Lopez-Ramirez; Ningzhe Zhang; Kuruwitage Lakshika Madushani; Stanislav Moroz; Ashley Loureiro; Katherine H Schreiber; Felix Hausch; Brian K Kennedy; Michelle E Ehrlich; Lisa M Ellerby
Journal:  Autophagy       Date:  2021-05-24       Impact factor: 16.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.